|
CodeMap® Compliance Briefing: May 12, 2022
Editor's Welcome:
Today's CodeMap® Compliance Briefing includes an interview of the Medical Director of the MolDX program performed earlier this spring by our colleagues at Laboratory Economics. The interview offers key insights into how the program works and the concerns and goals of its leadership. Amy laboratory developing and/or performing molecular diagnostics must pay close attention to the MolDX program if it expects to obtain favorable coverage policy and remain in compliance with the applicable rules and regulations of the Medicare program. As always, please forward any comments, suggestions, and/or questions to us via email.
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2022 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.
|
